Abstract:Oxidative stress (OS) is a metabolic dysfunction mediated by the imbalance between the biochemical processes leading to elevated production of reactive oxygen species (ROS) and the antioxidant defense system of the body. It has a ubiquitous role in the development of numerous noncommunicable maladies including cardiovascular diseases, cancers, neurodegenerative diseases, aging and respiratory diseases. Diseases associated with metabolic dysfunction may be influenced by changes in the redox balance. Lately, there has been increasing awareness and evidence that diabetes mellitus (DM), particularly type 2 diabetes, is significantly modulated by oxidative stress. DM is a state of impaired metabolism characterized by hyperglycemia, resulting from defects in insulin secretion or action, or both. ROS such as hydrogen peroxide and the superoxide anion introduce chemical changes virtually in all cellular components, causing deleterious effects on the islets of β-cells, in turn affecting insulin production. Under hyperglycemic conditions, various signaling pathways such as nuclear factor-κβ (NF-κβ) and protein kinase C (PKC) are also activated by ROS. All of these can be linked to a hindrance in insulin signaling pathways, leading to insulin resistance. Hyperglycemia-induced oxidative stress plays a substantial role in complications including diabetic nephropathy. DM patients are more prone to microvascular as well as atherosclerotic macrovascular diseases. This systemic disease affects most countries around the world, owing to population explosion, aging, urbanization, obesity, lifestyle, etc. However, some modulators, with their free radical scavenging properties, can play a prospective role in overcoming the debilitating effects of OS. This review is a modest approach to summarizing the basics and interlinkages of oxidative stress, its modulators and diabetes mellitus. It may add to the understanding of and insight into the pathophysiology of diabetes and the crucial role of antioxidants to weaken the complications and morbidity resulting from this chronic disease.

The role of sirtuins in the regulatin of oxidative stress during the progress and therapy of type 2 diabetes mellitus

Relationship Between Oxidative Stress, ER Stress, and Inflammation in Type 2 Diabetes: The Battle Continues

Sirtuins and Type 2 Diabetes: Role in Inflammation, Oxidative Stress, and Mitochondrial Function

Distinctive Roles of Sirtuins on Diabetes, Protective or Detrimental?

Nrf2 in Type 2 Diabetes and Diabetic Complications: Yin and Yang

The Nrf2/Keap1/ARE Pathway and Oxidative Stress as a Therapeutic Target in Type II Diabetes Mellitus

Molecular Mechanism of Islet Β-Cell Functional Alternations During Type 2 Diabetes.

Β-Cell Dynamics in Type 2 Diabetes and in Dietary and Exercise Interventions

Phytochemical activators of Nrf2: a review of therapeutic strategies in diabetes

Novel Role of the SIRT1 in Endocrine and Metabolic Diseases

Multiple Roles of SIRT2 in Regulating Physiological and Pathological Signal Transduction

Decreased Sirt3 Contributes to Cyclic Production of Reactive Oxygen Species and Islet Β-Cell Apoptosis in High Glucose Conditions

Sirt3 Deficiency Increased the Vulnerability of Pancreatic Beta Cells to Oxidative Stress-Induced Dysfunction

Sirtuins and Insulin Resistance

Mechanistic Insight into Oxidative Stress-Triggered Signaling Pathways and Type 2 Diabetes

Molecular Mechanisms Linking Oxidative Stress and Diabetes Mellitus

Oxidative Stress in Diabetes Mellitus and Its Complications: from Pathophysiology to Therapeutic Strategies

Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications

Advances in the Role of SIRT3-mediated Mitochondrial Function and Metabolic Regulation in Diabetes Mellitus Type 2

The correlation between S-nitrosylation and type 2 diabetes mellitus: a review

SIRT1–SIRT7 in Diabetic Kidney Disease: Biological Functions and Molecular Mechanisms